3-Bromopyridine → 5-[1-(2-methylpropyl)-1H-pyrazol-4-yl]-N-[(3S)-1-(pyridazin-4-yl)pyrrolidin-3-yl]thiophene-2-carboxamide

反応式

Br[C:2]1[CH:3]=[N:4]C=[CH:6][CH:7]=1.[CH2:8]([N:12]1[CH:16]=[C:15]([C:17]2[S:21][C:20]([C:22]([NH:24][C@H:25]3[CH2:29][CH2:28][NH:27][CH2:26]3)=[O:23])=[CH:19][CH:18]=2)[CH:14]=[N:13]1)[CH:9]([CH3:11])[CH3:10].[NH:30]1CC(C(NC2C=CC(OC3CCN(C(OC(C)(C)C)=O)CC3)=CC=2)=O)C1>>[CH3:10][CH:9]([CH3:11])[CH2:8][N:12]1[CH:16]=[C:15]([C:17]2[S:21][C:20]([C:22]([NH:24][C@H:25]3[CH2:29][CH2:28][N:27]([C:7]4[CH:2]=[CH:3][N:4]=[N:30][CH:6]=4)[CH2:26]3)=[O:23])=[CH:19][CH:18]=2)[CH:14]=[N:13]1

参加物

反応物 3

HCID 122863-Bromopyridine

HCID 86702036Tert-butyl 4-(4-(azetidine-3-carboxamido)phenoxy)piperidine-1-carboxylate

HCID 86702056(S)-5-(1-isobutyl-1H-pyrazol-4-yl)-N-(pyrrolidin-3-yl)thiophene-2-carboxamide

生成物 1

HCID 867020555-[1-(2-methylpropyl)-1H-pyrazol-4-yl]-N-[(3S)-1-(pyridazin-4-yl)pyrrolidin-3-yl]thiophene-2-carboxamide

実験手順

The title compound was prepared as described in Example 1C, substituting 4-bromopyridazine for 3-bromopyridine and (S)-5-(1-isobutyl-1H-pyrazol-4-yl)-N-(pyrrolidin-3-yl)thiophene-2-carboxamide for tert-butyl 4-(4-(azetidine-3-carboxamido)phenoxy)piperidine-1-carboxylate. 1H NMR (300 MHz, DMSO-d6) δ ppm 0.75-0.98 (m, 6 H) 1.98-2.44 (m, 3 H) 3.67-4.18 (m, 6 H) 4.66 (s, 1 H) 7.15 (dd, J=7.12, 3.05 Hz, 1 H) 7.21 (d, J=3.73 Hz, 1 H) 7.54-7.91 (m, 2 H) 8.14 (s, 1 H) 8.56-8.95 (m, 3 H); MS (ESI(+)) m/e 397 (M+H)+.